SII launches India’s 1st fully indigenously developed pneumococcal vaccine, Pneumosil Pneumosil is similar as the paediatric pneumococcal vaccine already on the market and targets serotypes 1, 5, 6A, 6B, 7F, 9V, 14,…
Serum Institute of India develops affordable pneumonia vaccine This will enable countries and treatment providers to procure more affordable versions of the vaccine, which has been out of reach…
